Study of Pancreatic Lesions in Transgenic Mice
Author Information
Author(s): Liao Dezhong Joshua, Wang Yong, Wu Jiusheng, Adsay Nazmi Volkan, Grignon David, Khanani Fayyaz, Sarkar Fazlul H
Primary Institution: Wayne State University School of Medicine and Karmanos Cancer Institute
Hypothesis
To identify good animal models for investigating therapeutic and preventive strategies for pancreatic cancer.
Conclusion
The study found that various transgenic mouse models exhibit different types of pancreatic lesions, making them suitable for research on pancreatic cancer.
Supporting Evidence
- Female MT-tgfα mice developed severe pancreatic lesions, while males showed less severe lesions.
- Ela-myc mice developed pancreatic tumors at 2–7 months of age, with some tumors metastasizing to the liver.
- MT-tgfα/Ela-myc double transgenic mice exhibited a higher frequency of liver metastasis compared to Ela-myc mice.
Takeaway
Scientists looked at mice with specific genes to see how they develop pancreatic cancer, which helps in finding better treatments.
Methodology
The study involved analyzing pancreatic lesions from various transgenic mouse models and performing histological examinations.
Potential Biases
Potential bias in the selection of transgenic lines and the interpretation of histological data.
Limitations
The study's sample size was relatively small, and the findings may not be generalizable to all pancreatic cancer models.
Participant Demographics
The study involved various transgenic mouse lines with mixed genetic backgrounds.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website